We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+12.06%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$2.32B
AUM Growth
+$183M
Cap. Flow
+$191M
Cap. Flow %
8.24%
Top 10 Hldgs %
64.77%
Holding
46
New
3
Increased
2
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
ALLK
Allakos
ALLK
+$93.1M
2
LQDA icon
Liquidia Corp
LQDA
+$40.8M
3
BE icon
Bloom Energy
BE
+$37.3M
4
ADAP
Adaptimmune Therapeutics
ADAP
+$26.2M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$2.35M

Top Sells

Rank Stock Value
1
MDB icon
MongoDB
MDB
+$7.45M
2
TNTR
Tintri, Inc. Common Stock
TNTR
+$1.3M
3
RGLS
Regulus Therapeutics
RGLS
+$264

Sector Composition

Rank Sector Weight
1 Healthcare 94.39%
2 Industrials 1.96%
3 Technology 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKAO
26
DELISTED
Achaogen Inc
AKAO
$20.8M 0.9%
5,215,128
– –
SBBP
27
DELISTED
Strongbridge Biopharma plc.
SBBP
$20.1M 0.87%
4,141,308
– –
GNCA
28
DELISTED
Genocea Biosciences, Inc.
GNCA
$19.5M 0.84%
3,125,000
– –
VRNA
29
DELISTED
Verona Pharma
VRNA
$15.3M 0.66%
1,219,674
– –
NITE
30
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$14.6M 0.63%
714,285
– –
ARQL
31
DELISTED
Arqule Inc
ARQL
$14.3M 0.62%
2,520,316
– –
DZSI
32
DELISTED
DZS Inc. Common Stock
DZSI
$13.6M 0.59%
956,255
– –
KA
33
DELISTED
Kineta, Inc. Common Stock
KA
$13.4M 0.58%
39,691
– –
RIGL icon
34
Rigel Pharmaceuticals
RIGL
$693M
$10.4M 0.45%
324,315
– –
CTIC
35
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$8.1M 0.35%
3,750,000
– –
TRVN
36
DELISTED
Trevena, Inc.
TRVN
$8.08M 0.35%
6,099
– –
TRIL
37
DELISTED
Trillium Therapeutics Inc.
TRIL
$7.25M 0.31%
1,250,000
– –
TCON
38
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$7.11M 0.31%
17,336
– –
PHXM
39
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$5.36M 0.23%
62,500
– –
ELGX
40
DELISTED
Endologix Inc
ELGX
$4.76M 0.21%
249,020
– –
XFOR icon
41
X4 Pharmaceuticals
XFOR
$386M
$3.24M 0.14%
11,111
– –
VIRX
42
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.6M 0.11%
37,094
– –
AKTX
43
Akari Therapeutics
AKTX
$12.9M
$1.16M 0.05%
565
– –
AYTU icon
44
AYTU BioPharma
AYTU
$24.1M
$6K ﹤0.01%
11
– –
MDB icon
45
MongoDB
MDB
$28.8B
– –
-150,000
Closed -$7.45M
TNTR
46
DELISTED
Tintri, Inc. Common Stock
TNTR
– –
-5,253,358
Closed -$1.3M
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return

NEA Management Company's Q3 2018 Portfolio in Review

As of Q3 2018, NEA Management Company held 46 positions worth $2.32B, up 8.6% from $2.13B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

NEA Management Company deployed $191M of net new capital in Q3 2018, opening 3 new positions and adding to 2 existing holdings. Its largest new stake was Allakos: 2,268,188 shares worth $102M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Regulus Therapeutics, an estimated $264 trimmed.

  • NEA Management Company's largest Q3 2018 buy was Allakos: 2,268,188 shares worth $102M.
  • NEA Management Company added most to Adaptimmune Therapeutics in Q3 2018, an estimated $26.2M increase.
  • NEA Management Company's biggest Q3 2018 reduction was Regulus Therapeutics, cutting an estimated $264.
  • NEA Management Company fully exited MongoDB in Q3 2018, selling an estimated $7.45M.
  • NEA Management Company's ten largest holdings make up 65% of its $2.32B portfolio in Q3 2018.
  • NEA Management Company opened 3 new positions and closed 2 in Q3 2018.
  • NEA Management Company's portfolio value rose 8.6% quarter-over-quarter to $2.32B.

Based on NEA Management Company's 13F filing for Q3 2018, filed 13 Nov 2018.